Cargando…
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123
CD123, the alpha chain of the IL-3 receptor, is an attractive target for acute myeloid leukemia (AML) treatment. However, cytotoxic antibodies or T cell engagers targeting CD123 had insufficient efficacy or safety in clinical trials. We show that expression of CD64, the high-affinity receptor for hu...
Autores principales: | Gauthier, Laurent, Virone-Oddos, Angela, Beninga, Jochen, Rossi, Benjamin, Nicolazzi, Céline, Amara, Céline, Blanchard-Alvarez, Audrey, Gourdin, Nicolas, Courta, Jacqueline, Basset, Alexandra, Agnel, Magali, Guillot, Franceline, Grondin, Gwendoline, Bonnevaux, Hélène, Bauchet, Anne-Laure, Morel, Ariane, Morel, Yannis, Chiron, Marielle, Vivier, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497414/ https://www.ncbi.nlm.nih.gov/pubmed/36635380 http://dx.doi.org/10.1038/s41587-022-01626-2 |
Ejemplares similares
-
Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment
por: Bonnevaux, Hélène, et al.
Publicado: (2021) -
A novel mucosal RORγt(+)NKp46(+) cell subset is a source of interleukin-22
por: Tomasello, Elena, et al.
Publicado: (2009) -
Expansion microscopy with carboxylic trifunctional linkers: Expansion microscopy with carboxylic trifunctional linkers
por: Chen, Xuecheng, et al.
Publicado: (2022) -
Mapping of NKp46(+) Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues
por: Tomasello, Elena, et al.
Publicado: (2012) -
Innate-like NKp30(+)CD8(+) T cells armed with TCR/CAR target tumor heterogeneity
por: Correia, Margareta P., et al.
Publicado: (2021)